For research use only. Not for therapeutic Use.
Bimosiamose（Cat No.:M037878）is a synthetic tetrasaccharide that acts as a selectin inhibitor, used primarily in anti-inflammatory and immunomodulatory research. By blocking selectin-mediated cell adhesion, it prevents leukocyte migration to sites of inflammation, making it a promising candidate for treating conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other inflammatory diseases. Its high specificity and efficacy ensure reliable results in preclinical and clinical studies. Bimosiamose is crucial for developing novel therapeutic strategies aimed at controlling inflammation and immune responses, contributing significantly to advancements in medical research and treatment options.
| Catalog Number | M037878 |
| CAS Number | 187269-40-5 |
| Synonyms | 2-[3-[5-[6-[3-[3-(carboxymethyl)phenyl]-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hexyl]-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]phenyl]acetic acid |
| Molecular Formula | C46H54O16 |
| Purity | ≥95% |
| IUPAC Name | 2-[3-[5-[6-[3-[3-(carboxymethyl)phenyl]-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hexyl]-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]phenyl]acetic acid |
| InChI | InChI=1S/C46H54O16/c47-23-35-39(53)41(55)43(57)45(61-35)59-33-15-13-25(19-31(33)29-11-5-9-27(17-29)21-37(49)50)7-3-1-2-4-8-26-14-16-34(60-46-44(58)42(56)40(54)36(24-48)62-46)32(20-26)30-12-6-10-28(18-30)22-38(51)52/h5-6,9-20,35-36,39-48,53-58H,1-4,7-8,21-24H2,(H,49,50)(H,51,52)/t35-,36-,39-,40-,41+,42+,43+,44+,45+,46+/m1/s1 |
| InChIKey | RYWCQJDEHXJHRI-XJMXIVSISA-N |
| SMILES | C1=CC(=CC(=C1)C2=C(C=CC(=C2)CCCCCCC3=CC(=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O)C5=CC=CC(=C5)CC(=O)O)OC6C(C(C(C(O6)CO)O)O)O)CC(=O)O |
